Agenus, Inc. (AGEN)
8.36
+0.03
(+0.36%)
USD |
NASDAQ |
Oct 02, 16:00
8.345
-0.02
(-0.18%)
After-Hours: 20:00
Agenus Profit Margin (Quarterly) : -1.64% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.64% |
| March 31, 2026 | |
| December 31, 2025 | -31.03% |
| September 30, 2025 | |
| June 30, 2025 | -116.8% |
| March 31, 2025 | -109.6% |
| December 31, 2024 | -174.4% |
| September 30, 2024 | -267.7% |
| June 30, 2024 | -233.1% |
| March 31, 2024 | -226.6% |
| December 31, 2023 | -57.97% |
| September 30, 2023 | -265.4% |
| June 30, 2023 | -290.3% |
| March 31, 2023 | -309.5% |
| December 31, 2022 | -261.1% |
| September 30, 2022 | -249.1% |
| June 30, 2022 | -235.3% |
| March 31, 2022 | -195.1% |
| December 31, 2021 | -333.7% |
| September 30, 2021 | 70.08% |
| June 30, 2021 | -782.8% |
| March 31, 2021 | -464.2% |
| December 31, 2020 | -120.7% |
| September 30, 2020 | -348.2% |
| June 30, 2020 | -179.0% |
| Date | Value |
|---|---|
| March 31, 2020 | -299.3% |
| December 31, 2019 | -89.42% |
| September 30, 2019 | -232.1% |
| June 30, 2019 | -330.0% |
| March 31, 2019 | 21.82% |
| December 31, 2018 | -757.2% |
| September 30, 2018 | -263.5% |
| June 30, 2018 | -158.6% |
| March 31, 2018 | -3.32K% |
| December 31, 2017 | -419.4% |
| September 30, 2017 | -1.10K% |
| June 30, 2017 | -753.7% |
| March 31, 2017 | -63.45% |
| December 31, 2016 | -468.5% |
| September 30, 2016 | -917.0% |
| June 30, 2016 | -429.6% |
| March 31, 2016 | -533.3% |
| December 31, 2015 | -204.3% |
| September 30, 2015 | -191.6% |
| June 30, 2015 | -633.7% |
| March 31, 2015 | -474.1% |
| December 31, 2014 | -1.60K% |
| September 30, 2014 | -518.7% |
| June 30, 2014 | -252.5% |
| March 31, 2014 | -49.59% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novavax, Inc. | -94.16% |
| Amgen, Inc. | 23.59% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
| Curis, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 45.74% |
| Return on Invested Capital | 133.5% |
| Gross Profit Margin (Quarterly) | 98.50% |
| Operating Margin (Quarterly) | 32.72% |
| Return on Net Operating Assets | 94.95% |